Abstracts tagged "classification criteria"

Abstract Number: 1584 • 2018 ACR/ARHP Annual Meeting
Evaluation of the Performance of the 2016 American College of Rheumatology-European League Against Rheumatism (Acr-Eular) Classification Criteria for Primary Sjogren`S Syndrome in Different Centers of Argentina
Hugo Najera¹, Marta Mamani², Anastasia Secco¹, Fernando Melo³, Cristian Troitiño⁴, Felix Romanini Sr.², Emmanuel Guerra², Antonio Catalan Pellet⁵, Silvia Beatriz Papasidero⁶, Rodrigo Aguila Maldonado⁷, Mercedes Garcia⁷, Mariano Rivero⁸, Juan Carlos Barreira⁹, ivan remolina¹⁰, A. perdomo¹¹, quevedo mayorga¹⁰, M.J. santacruz¹² and j demarchi¹⁰, ¹Rheumatology Section, Hospital Bernardino Rivadavia, CABA, Argentina, ²Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ³Rheumatology Department, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ⁴Reumatologia, Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina, ⁵Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ⁶Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, Buenos Aires, Argentina, ⁷Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, ⁸Rheumatology, Consultorios Externos Vacarezza,Alberdi,Pcia Buenos Aires, Pcia Buenos Aires, Argentina, ⁹Rheumatology Unit, Hospital Británico, Buenos Aires, Buenos Aires, Argentina, ¹⁰hospital britanico, Buenos Aires, Argentina, ¹¹hospital nuestra señora de la merced, alberti, Argentina, ¹²hospital tornu, Buenos Aires, Argentina
Background/Purpose: Primary Sjögren`s Syndrome (pSS) is a multisystemic, autoimmunity disease, characterized mainly by the hypofunction of the salivary and lacrimal glands, however the clinical spectrum…
Abstract Number: 1681 • 2018 ACR/ARHP Annual Meeting
Performance of the Proposed American College of Rheumatology / European League Against Rheumatism 2017 Classification Criteria for SLE in Adult and Juvenile Systemic Lupus Erythematosus and Other Anti-Nuclear Antibody Related Rheumatic Diseases
Chengappa KG¹, Gunjan Kumar², Swaminathan R P³ and Vir Singh Negi¹, ¹Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India, ²Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India, ³Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
Background/Purpose: A new classification criteria for SLE was proposed at the ACR/ARHP 2017 annual meet. The aim of this study was to compare the performance…
Abstract Number: 1690 • 2018 ACR/ARHP Annual Meeting
Increased Sensitivity Οf Τhe New (2017) Αnd Τhe 2012 SLICC As Compared Τo Τhe Acr 1997 Classification Criteria Ιn Early Systemic Lupus Erythematosus (SLE): The 2017 Αnd 2012 Criteria May Classify Non-Overlapping Subgroups Οf Patients
Christina Adamichou¹, Dionysios Nikolopoulos², Alessandra Bortoluzzi³, Emmanouil Papastefanakis¹, Antonis Fanouriakis², Eleni Kalogiannaki¹, Irini Gergianaki¹, Prodromos Sidiropoulos¹ and George Bertsias¹, ¹Department of Rheumatology, Clinical Immunology and Allergy, University of Crete, School of Medicine, Heraklion, Greece, ²4th Department of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece, ³Section of Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-University Hospital S. Anna, Cona Ferrara, Italy
Background/Purpose: SLE diagnosis can be challenging especially at the early stages, and existing classification criteria are biased towards classifying patients with long-standing disease. A joined…
Abstract Number: 2298 • 2018 ACR/ARHP Annual Meeting
Developing a Classification Criteria for Cutaneous Dermatomyositis Utilizing the Delphi Technique
Josef Concha¹, Victoria P. Werth¹, Joseph F. Merola², David Fiorentino³, Jan Dutz⁴, Manabu Fujimoto⁵, Mark Goodfield⁶, Chia-Chun Ang⁷, Filippa Nyberg⁸ and Beatrix Volc-Platzer⁹, ¹University of Pennsylvania, Philadelphia, PA, ²Clinical Unit for Research Innovation & Trials, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Dermatology, Stanford University School of Medicine, Stanford, CA, ⁴Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, ⁵University of Tsukuba, Faculty of Medicine, Department of Dermatology, Tsukuba, Japan, ⁶Leeds General Infirmary, Leeds, United Kingdom, ⁷Changi General Hospital, Singapore, Singapore, ⁸Karolinska Institute, Solna, Sweden, ⁹Wiener Krankenanstaltenverbund, Vienna, Austria
Background/Purpose: The new European League Against Rheumatism / American College of Rheumatology (EULAR / ACR) classification criteria for inflammatory myopathies are able to identify patients…
Abstract Number: 2702 • 2018 ACR/ARHP Annual Meeting
Incidence, Prevalence, Mortality and Comparison of the Acr/EULAR 2013 Classification Criteria with 1980 Criteria in Physician Diagnosed Systemic Sclerosis: Results from a Population Based Cohort (1980-2016)
Avneek Singh Sandhu¹, Cynthia S. Crowson², Philippe R. Bauer³, Eric L. Matteson⁴ and Ashima Makol¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ⁴Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: Systemic Sclerosis (SSc) is a complex and heterogenous chronic inflammatory disease characterized by widespread fibrosis of the skin and visceral organs, microvascular injury and…
Abstract Number: 2921 • 2018 ACR/ARHP Annual Meeting
The Performance of the Newly Proposed EULAR/Acr Classification Criteria in Juvenile-Onset Systemic Lupus Erythematosus
Sezgin Sahin¹, Sule Bektas¹, Amra Adrovic¹, Oya Koker², Kenan Barut¹ and Ozgur Kasapcopur³, ¹Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ²Istanbul University, Istanbul Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ³Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey
Background/Purpose: To avoid misclassifications, a new set of classification criteria have been developed by the collaboration of the EULAR/ACR and the draft was presented at…
Abstract Number: 2935 • 2018 ACR/ARHP Annual Meeting
A Practical Classification of Systemic Sclerosis Using Subset and Autoantibodies for the Purpose of Early Risk Stratification
Svetlana I. Nihtyanova¹, Emma C. Derrett-Smith², Carmen Maria Fonseca³, Voon H. Ong² and Christopher P. Denton⁴, ¹Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, ²Division of Medicine, University College London, London, United Kingdom, ³Department of Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, ⁴University College London, London, United Kingdom
Background/Purpose: The Le Roy et al. classification of SSc into limited and diffuse cutaneous subtype remains the most commonly used. Nevertheless, autoantibodies are much better…
Abstract Number: 2978 • 2018 ACR/ARHP Annual Meeting
Performance of the 2017 European League Against Rheumatism / American College of Rheumatology (EULAR/ACR) Classification Criteria for Adult Idiopathic Inflammatory Myopathies (IIM) in an Australian Cohort
Queenie Luu¹, Jessica Day^2,3, Alix Hall⁴, Vidya Limaye^2,5 and Gabor Major^6,7, ¹Rheumatology, Bone and Joint Institute, John Hunter Hospital, New Lambton Heights, Australia, ²Rheumatology, The Royal Adelaide Hospital, Adelaide, Australia, ³School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia, ⁴Hunter Medical Research Institute, New Lambton Heights, Australia, ⁵Discipline of Medicine, University of Adelaide, South Australia, Adelaide, Australia, ⁶Rheumatology, Bone and Joint Institute, John Hunter Hospital, Newcastle, Australia, ⁷University of Newcastle, Newcastle, Australia, Newcastle, Australia
Background/Purpose: EULAR/ACR recently approved classification criteria for idiopathic inflammatory myopathies (IIM) with 93% sensitivity and 88% specificity. An acknowledged limitation of the study is the…
Abstract Number: 2556 • 2017 ACR/ARHP Annual Meeting
Were Moll and Wright Right?
Sergio Schwartzman¹, Madeline Epsten², Jackie Szymonifka², Stephen A. Paget³ and Lisa A. Mandl¹, ¹Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Division of Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY
Background/Purpose: In 1973 Moll and Wright published the first paper on the classification criteria for Psoriatic Arthritis (PsA). In their pioneering work, these authors additionally…
Abstract Number: 877 • 2017 ACR/ARHP Annual Meeting
Modification of the Classification Criteria for Primary Sjögren Syndrome: An International Vignette Survey
Sandrine Jousse-Joulin¹, Florence Gatineau², Chiara Baldini³, Alan N. Baer⁴, Francesca Barone⁵, Hendrika Bootsma⁶, Simon Bowman⁷, Pilar Brito Zeron⁸, Divi Cornec⁹, Thomas Doerner¹⁰, Salvatore De Vita¹¹, Benjamin Fisher¹², Daniel S. Hammenfors¹³, Malin V. Jonsson¹⁴, Xavier Mariette¹⁵, Vera Milic¹⁶, Hideki Nakamura¹⁷, Wan-Fai Ng¹⁸, Emmanuel Nowak², Manuel Ralos-Casals¹⁹, Astrid Rasmussen²⁰, Raphaèle Seror²¹, Caroline Shiboski²², Takashi Nakamura²³, Arjan Vissink²⁴, Alain Saraux²⁵ and Valérie Devauchelle-Pensec¹, ¹Rheumatology, Brest university medical school, EA 2216, UBO and CHU de la Cavale Blanche,, Brest, France, ²INSERM CIC 1412, Brest Medical University Hospital, Brest, France, ³Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, ⁴Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, ⁶Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands, ⁷Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, ⁸Autoimmune Diseases Unit, Department of Internal Medicine, Hospital CIMA-Sanitas, Barcelona, Spain, ⁹CHU Brest, Brest, France, ¹⁰Charité Universitätmedizin Berlin and DRFZ, Berlin, Germany, ¹¹Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, ¹²Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom, ¹³Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, Bergen, Norway, ¹⁴Section for Oral and Maxillofacial Radiology, Department of Clinical Dentistry, University of Bergen, Bergen, Norway, Bergen, Norway, ¹⁵Université Paris Sud, Paris, France, ¹⁶Institute of Rheumatology, School of Medicine, University of Belgrade, Belgrade, Serbia, ¹⁷Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ¹⁸Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, ¹⁹Department of Medicine, University of Barcelona, Barcelone, Spain, ²⁰Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²¹Assistance Publique-Hôpitaux de Paris (APHP), Hôpitaux universitaires Paris Sud, Université Paris Sud, kremlin bicetre, France, ²²Department of Orofacial Sciences, School of Dentistry, University of California, San Francisco, CA, ²³Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Nagasaki, Japan, ²⁴Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ²⁵Rheumatology Department, Rheumatology Department, CHU de la Cavale Blanche, Brest, France, Brest Cedex, France
Background/Purpose: The common classification criteria sets of primary Sjogren syndrome, did not considered the ultrasonography (US) of the major salivary glands as a useful item.…
Abstract Number: 1172 • 2017 ACR/ARHP Annual Meeting
Utility of Interstitial Pneumonia with Autoimmune Features (IPAF) Proposed Criteria in the Classification of Patients with CTD-Associated Interstitial Lung Disease in a Single Centre
Fredeswinda I. Romero-Bueno¹, Ana Sofía Pozo², Maria Jesus Rodriguez-Nieto³, Maria José Martinez-Becerra⁴, Gabriel Herrero-Beaumont⁵ and Olga Sanchez-Pernaute¹, ¹Section for Autoimmune Diseases, Rheumatology, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ²Faculty of Medicine, Autonoma University of Madrid, Madrid, Spain, ³Pulmonary Medicine, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ⁴Immunology, Jiménez Díaz Foundation University Hospital, Madrid, Spain, ⁵Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain
Background/Purpose: The term interstitial pneumonia with autoimmune features (IPAF) has recently been proposed to identify those patients with ILD and clinical and/or serological autoimmune manifestations…
Abstract Number: 1289 • 2017 ACR/ARHP Annual Meeting
Assessing ACR/EULAR Provisional 2017 Classification Criteria for Granulomatosis with Polyangiitis (GPA) in a Cohort of 376 Children with Small to Medium Vessel Chronic Vasculitis – a Pediatric Vasculitis Initiative (PedVas) Study
Angelyne Rivera¹, Kimberly Morishita², David Cabral² and Raashid Luqmani³, ¹Pediatrics, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, ²BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, ³Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom
Background/Purpose: Classification of chronic vasculitis to clinically or etiologically meaningful groups has been challenging. In 2008, the 1990 ACR classification criteria for GPA was adapted…
Abstract Number: 1397 • 2017 ACR/ARHP Annual Meeting
American College of Rheumatology Response Rates Determined Using 28 Versus 68/66 Joint Count in Patients with Rheumatoid Arthritis Receiving Tofacitinib in Phase 3 Studies
Josef S. Smolen¹, William Shergy², Grace C. Wright³, Ryan DeMasi⁴, Kenneth Kwok⁵, Christopher F Mojcik⁵, Noriko Iikuni⁵, Svitlana Tatulych⁶ and Gustavo Citera⁷, ¹Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ²Rheumatology Associates of North Alabama, Huntsville, AL, ³NYU Langone Medical Center, New York, NY, ⁴Pfizer Inc, Collegeville, PA, ⁵Pfizer Inc, New York, NY, ⁶Pfizer Inc, Groton, CT, ⁷Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). In a clinical trial setting, standard criteria for measuring the…
Abstract Number: 1589 • 2017 ACR/ARHP Annual Meeting
A Multicriteria Decision Analysis for the Development of New Systemic Lupus Erythematosus Classification Criteria
Sara K. Tedeschi¹, Sindhu Johnson², Dimitrios Boumpas³, David I. Daikh⁴, Betty Diamond⁵, Thomas Doerner⁶, Søren Jacobsen⁷, Diane L. Kamen⁸, W. Joseph McCune⁹, Marta Mosca¹⁰, Rosalind Ramsey-Goldman¹¹, Guillermo Ruiz-Irastorza¹², Matthias Schneider¹³, Josef S. Smolen¹⁴, Murray Urowitz¹⁵, David Wofsy¹⁶, Martin Aringer¹⁷, Raymond P. Naden¹⁸ and Karen H. Costenbader^19,20, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Rheumatology, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada, ³University of Athens, Athens, Greece, ⁴Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁵Feinstein Institute for Medical Research, Manhasset, NY, ⁶Charité Universitätmedizin Berlin and DRFZ, Berlin, Germany, ⁷Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, ⁸Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ⁹Int Med/ Rheum, University of Michigan, Ann Arbor, MI, ¹⁰Rheumatology Unit, University of Pisa, Pisa, Italy, ¹¹FSM, Northwestern University, Chicago, IL, ¹²Autoimmune Diseases Research Unit, BioCruces, Hospital Universitario Cruces, Baracaldo, Spain, ¹³Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ¹⁴Division of Rheumatology, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ¹⁵Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ¹⁶Rheumatology, UCSF, San Francisco, CA, ¹⁷Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany, ¹⁸New Zealand Ministry of Health, New Zealand Ministry of Health, Auckland, New Zealand, ¹⁹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²⁰Rheumatology, Immunology & Allergy, Brigham & Women's Hospital, Boston, MA
Background/Purpose: EULAR and ACR are supporting multi-phase development of SLE classification criteria based on weighted criteria and a continuous probability scale. Prior steps included criteria…
Abstract Number: 2048 • 2017 ACR/ARHP Annual Meeting
the Impact of Diagnostic Misregistration of Rheumatoid Arthritis on the Establishment of a Value Based Healthcare System
Nienke Conijn^1,2, Deirisa Lopes Barreto¹, Martijn Kuijper¹, Matthijs van der Steen³, Jaco van der Kooij⁴, Angelique Weel^2,5, J.M.W. Hazes² and Marc R Kok¹, ¹Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, ²Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, ³Business Intelligence, Maasstad Hospital, Rotterdam, Netherlands, ⁴Planning and Control, Maasstad Hospital, Rotterdam, Netherlands, ⁵Department of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands
Background/Purpose: Value based health care has gained worldwide attention due to the refocusing vision of creating value around and for patients. The latter is obtained…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].